๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
HI-PAD is a placebo controlled double-blind randomized pilot clinical trial...
Status
Completed
Location
Northwestern University
Start Date
2018-01-01
Trial ID
NCT03363165
As \< 10% of the necessary patients required by the protocol were recruited...
Status
Terminated
Location
LAC-USC Medical Center
Start Date
2012-01
Trial ID
NCT01521143
This phase 2 clinical trial will investigate an optimal dose, dosing regime...
Status
Active Not Recruiting
Location
Benchmark Research
Start Date
2025-03-10
Trial ID
NCT06899802
Treatments Being Tested
In people with type 1 diabetes the beta cells of the pancreas no longer mak...
Status
Completed
Location
The Children's Hospital at Westmead
Start Date
2006-12
Trial ID
NCT00336674
Treatments Being Tested
The purpose of this phase 3 multicenter, randomized, double-blind, placebo-...
Status
Active Not Recruiting
Location
Alliance for Multispecialty Research, LLC
Start Date
2023-08-30
Trial ID
NCT06007183
Treatments Being Tested
The purpose of this study is to evaluate the efficacy, safety and immunogen...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-10
Trial ID
NCT05067946
The purpose of this phase 3, randomized, double-blind, placebo-controlled s...
Status
Completed
Location
Suncoast Research Associates, LLC
Start Date
2022-05-12
Trial ID
NCT05349617
Treatments Being Tested
To determine the safety and efficacy of an intracoronary injection of adeno...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-06
Trial ID
NCT03360448
To investigate safety, tolerability, the effects on cognition and brain met...
Status
Completed
Location
Pacific Research Network, Inc
Start Date
2021-07-22
Trial ID
NCT04381468
AD17002 enhances nasal mucosal innate immunity and has met safety and effic...
Status
Terminated
Location
RSPI Sulianti Saroso
Start Date
2022-12-01
Trial ID
NCT05541510
Treatments Being Tested